Cargando…
MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers
MicroRNAs (miRNAs) are endogenous, non-coding, single-stranded, tiny RNAs with 21–23 nucleotides that regulate several biological functions through binding to target mRNAs and modulating gene expression at post-transcriptional levels. Recent studies have described crucial roles for miRNAs in pathoph...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354082/ https://www.ncbi.nlm.nih.gov/pubmed/32753896 http://dx.doi.org/10.2147/OTT.S249268 |
_version_ | 1783558010383106048 |
---|---|
author | Nazarizadeh, Ali Mohammadi, Forogh Alian, Fatemeh Faraji, Parisa Nourbakhsh, Mitra Alizadeh-Fanalou, Shahin |
author_facet | Nazarizadeh, Ali Mohammadi, Forogh Alian, Fatemeh Faraji, Parisa Nourbakhsh, Mitra Alizadeh-Fanalou, Shahin |
author_sort | Nazarizadeh, Ali |
collection | PubMed |
description | MicroRNAs (miRNAs) are endogenous, non-coding, single-stranded, tiny RNAs with 21–23 nucleotides that regulate several biological functions through binding to target mRNAs and modulating gene expression at post-transcriptional levels. Recent studies have described crucial roles for miRNAs in pathophysiology of numerous human cancers. They can act as an oncogene and promote cancer or as a tumor suppressor and alleviate the disease. Recently discovered microRNA-154 (miR-154) has been proposed to be involved in multiple physiological and pathological processes including cancer. With this aspect, aberrant expression of miR-154 has been demonstrated in variety of human malignancies, suggesting an important role for miR-154 in tumorigenesis. To be specific, it is considered as a tumor suppressor miRNA and exerts its beneficial effects by targeting several genes. This review systematically summarizes the recent advances done on the role of miR-154 in different cancers and discusses its potential prognostic, diagnostic and therapeutic values. |
format | Online Article Text |
id | pubmed-7354082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-73540822020-08-03 MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers Nazarizadeh, Ali Mohammadi, Forogh Alian, Fatemeh Faraji, Parisa Nourbakhsh, Mitra Alizadeh-Fanalou, Shahin Onco Targets Ther Review MicroRNAs (miRNAs) are endogenous, non-coding, single-stranded, tiny RNAs with 21–23 nucleotides that regulate several biological functions through binding to target mRNAs and modulating gene expression at post-transcriptional levels. Recent studies have described crucial roles for miRNAs in pathophysiology of numerous human cancers. They can act as an oncogene and promote cancer or as a tumor suppressor and alleviate the disease. Recently discovered microRNA-154 (miR-154) has been proposed to be involved in multiple physiological and pathological processes including cancer. With this aspect, aberrant expression of miR-154 has been demonstrated in variety of human malignancies, suggesting an important role for miR-154 in tumorigenesis. To be specific, it is considered as a tumor suppressor miRNA and exerts its beneficial effects by targeting several genes. This review systematically summarizes the recent advances done on the role of miR-154 in different cancers and discusses its potential prognostic, diagnostic and therapeutic values. Dove 2020-07-07 /pmc/articles/PMC7354082/ /pubmed/32753896 http://dx.doi.org/10.2147/OTT.S249268 Text en © 2020 Nazarizadeh et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Nazarizadeh, Ali Mohammadi, Forogh Alian, Fatemeh Faraji, Parisa Nourbakhsh, Mitra Alizadeh-Fanalou, Shahin MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers |
title | MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers |
title_full | MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers |
title_fullStr | MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers |
title_full_unstemmed | MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers |
title_short | MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers |
title_sort | microrna-154: a novel candidate for diagnosis and therapy of human cancers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354082/ https://www.ncbi.nlm.nih.gov/pubmed/32753896 http://dx.doi.org/10.2147/OTT.S249268 |
work_keys_str_mv | AT nazarizadehali microrna154anovelcandidatefordiagnosisandtherapyofhumancancers AT mohammadiforogh microrna154anovelcandidatefordiagnosisandtherapyofhumancancers AT alianfatemeh microrna154anovelcandidatefordiagnosisandtherapyofhumancancers AT farajiparisa microrna154anovelcandidatefordiagnosisandtherapyofhumancancers AT nourbakhshmitra microrna154anovelcandidatefordiagnosisandtherapyofhumancancers AT alizadehfanaloushahin microrna154anovelcandidatefordiagnosisandtherapyofhumancancers |